// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "MS LC RFC UBERON HCD sex OPTIONAL MUST DISCLAIMS PSI ID RECOMMENDED CF mass cleavage agent details USE VCF IMPORTANT FOR TA sample MIAME ANY OF ALL age COLUMN label EW IS STANDARDS fractionation method EFO MHC PATCH INFORMATION dissociation method EBI THE VK instrument II MAY PTM disease WILL PROTEOMICS CS DIA PARTICULAR INFRINGE biological replicate SHOULD SWATH fraction identifier PMID ZFA MINOR IAA THAT pooled sample MAGE TMT developmental stage REQUIRES JA RIGHTS LI REQUIRED QY depletion TIP PURPOSE MOD alkylation reagent FITNESS PEPTIDESEQ RAW BUT HUPO CN proteomics data acquisition method SDRF reduction reagent technical replicate TO ... BRENDA PRM INCLUDING WARRANTIES DTT URI exclamation PRIDE MERCHANTABILITY NOT AS OR individual WARRANTY ISA ROW III RECOMMEND HF disease stage BMC NT SILAC SN PRIDE:0000659 NCE PO MONDO replicate FDR source name ancestry category biosample accession number data file AC INITIATIVE IMPLIED cell type URL MC HEREIN file your NCBI CLO SP organism CID CT MT HANCESTRO BE TAB CL SRM SHALL MAJOR PP CPTAC spiked compound README DOID HTML XL BTO source name_ and _assay name EM ENVO NOTE collision energy LIMITED MS:1001251 CELL XML SH COULD CV DDA PMCID PS IDF organism part characteristics EXPRESS DJ PATO"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "MS LC RFC UBERON HCD sex OPTIONAL MUST DISCLAIMS PSI RECOMMENDED CF mass cleavage agent details USE VCF FOR TA MIAME ANY OF ALL age COLUMN label EW IS STANDARDS fractionation method EFO MHC PATCH INFORMATION dissociation method EBI THE VK instrument II MAY PTM disease WILL PROTEOMICS CS DIA PARTICULAR INFRINGE biological replicate SHOULD SWATH fraction identifier PMID ZFA MINOR IAA THAT pooled sample MAGE TMT REQUIRES JA RIGHTS LI REQUIRED QY depletion PURPOSE MOD alkylation reagent FITNESS PEPTIDESEQ RAW BUT HUPO CN proteomics data acquisition method SDRF reduction reagent technical replicate TO ... BRENDA PRM INCLUDING WARRANTIES DTT URI PRIDE MERCHANTABILITY NOT AS OR individual WARRANTY ISA ROW III RECOMMEND HF disease stage BMC NT SILAC SN PRIDE:0000659 NCE PO MONDO FDR ancestry category biosample accession number data file AC INITIATIVE IMPLIED cell type URL MC HEREIN NCBI CLO SP organism CID CT MT HANCESTRO BE TAB CL SRM SHALL MAJOR PP CPTAC spiked compound README DOID HTML XL BTO EM ENVO collision energy LIMITED MS:1001251 CELL SH COULD CV DDA PMCID PS IDF organism part EXPRESS DJ PATO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO:0005138 CL:0000235 MONDO:0004975 UBERON UBERON:0002113 sex MUST ID CL:0000182 DSS enrichment process IMPORTANT disease model ALL UBERON:0001969 CL:0000625 age CL:0000084 EFO MONDO:0005575 MONDO:0008383 UBERON:0000948 PATO:0000383 UBERON:0001088 MAY PTM APP disease NSG biological replicate SHOULD UBERON:0002107 PATO:0001340 MONDO:0005105 CL:0000898 MONDO:0005148 MONDO:0005180 developmental stage UBERON:0001155 depletion CL:0000913 TIP UBERON:0002048 UBERON:0000310 CL:0000236 SDRF lib CL:0000623 CL:0000066 CL:0000787 CL:0000233 UBERON:0002097 PATO:0000384 CL:0000540 PDX compound COVID exclamation MONDO:0004989 CL:0000451 individual CML CL:0000788 CL:0000576 CL:0000815 MONDO:0100096 CSF PO MONDO source name ancestry category NK UBERON:0001977 UBERON:0001359 MONDO:0004946 cell type URL synthetic peptide PATO:0000461 NCBI organism HANCESTRO CL MONDO:0005301 xenograft DOID CL:0000624 UBERON:0000955 NOTE CL:0000813 organism part CL:0000057 UBERON:0000178 PATO CL:0000232"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO:0005138 CL:0000235 MONDO:0004975 UBERON UBERON:0002113 sex MUST ID CL:0000182 DSS enrichment process disease model ALL UBERON:0001969 CL:0000625 age CL:0000084 EFO MONDO:0005575 MONDO:0008383 UBERON:0000948 PATO:0000383 UBERON:0001088 MAY PTM APP disease NSG biological replicate SHOULD UBERON:0002107 PATO:0001340 MONDO:0005105 CL:0000898 MONDO:0005148 MONDO:0005180 developmental stage UBERON:0001155 depletion CL:0000913 UBERON:0002048 UBERON:0000310 CL:0000236 SDRF CL:0000623 CL:0000066 CL:0000787 CL:0000233 UBERON:0002097 PATO:0000384 CL:0000540 PDX compound COVID MONDO:0004989 CL:0000451 individual CML CL:0000788 CL:0000576 CL:0000815 MONDO:0100096 CSF PO MONDO source name ancestry category NK UBERON:0001977 UBERON:0001359 MONDO:0004946 cell type URL synthetic peptide PATO:0000461 NCBI organism HANCESTRO CL MONDO:0005301 xenograft DOID CL:0000624 UBERON:0000955 CL:0000813 organism part CL:0000057 UBERON:0000178 PATO CL:0000232"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "sex ID GDPR NCIT:C28054 NCIT:C15313 IMPORTANT prior treatment NCIT:C14168 HANCESTRO:0005 age NCIT:C27971 TNM staging CHEBI:41774 ACE EFO BMI secondary condition UO NCIT:C53556 menopausal status II disease height NCIT:C27970 MONDO:0005148 NCIT:C14169 NCIT:C28076 NCI NCIT:C53553 NCIT:C27966 CHEBI:6801 NCIT:C28078 NCIT:C68804 MONDO:0005044 NCIT:C14167 SDRF treatment response treatment NCIT:C16358 NCIT:C81328 NCIT:C14174 pregnancy status treatment status sampling time point medication history compound time post treatment exclamation NCIT:C18213 MONDO:0004979 NCIT:C62723 NCIT individual NCIT:C15632 IV NCIT:C65106 diet breast cancer subtype MONDO:0005300 III NCIT:C4870 AJCC NCIT:C71732 disease stage MONDO gestational age PR MONDO:0004995 pre-existing condition ancestry category CHEBI:27899 Dukes stage organism smoking status NCIT:C28077 HANCESTRO NCIT:C15445 CHEBI:28748 NCIT:C81327 NCIT:C65108 tumor grade ethnicity TNM alcohol consumption HANCESTRO:0006 HANCESTRO:0010 MONDO:0002050 HANCESTRO:0009 dose NCIT:C53554 NOTE Ann Arbor stage ER NCIT:C15329 NCIT:C18206 NCIT:C53555 MONDO:0011122 NCIT:C15262 organism part PD NCIT:C28079 PREFERRED body mass index NCIT:C18058 HIPAA weight NCIT:C65107"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "sex ID GDPR NCIT:C28054 NCIT:C15313 prior treatment NCIT:C14168 HANCESTRO:0005 age NCIT:C27971 TNM staging CHEBI:41774 ACE EFO BMI secondary condition UO NCIT:C53556 menopausal status II disease height NCIT:C27970 MONDO:0005148 NCIT:C14169 NCIT:C28076 NCI NCIT:C53553 NCIT:C27966 CHEBI:6801 NCIT:C28078 NCIT:C68804 MONDO:0005044 NCIT:C14167 SDRF treatment response treatment NCIT:C16358 NCIT:C81328 NCIT:C14174 pregnancy status treatment status sampling time point medication history compound time post treatment NCIT:C18213 MONDO:0004979 NCIT:C62723 NCIT individual NCIT:C15632 IV NCIT:C65106 diet breast cancer subtype MONDO:0005300 III NCIT:C4870 AJCC NCIT:C71732 disease stage MONDO gestational age PR MONDO:0004995 pre-existing condition ancestry category CHEBI:27899 Dukes stage organism smoking status NCIT:C28077 HANCESTRO NCIT:C15445 CHEBI:28748 NCIT:C81327 NCIT:C65108 tumor grade ethnicity TNM alcohol consumption HANCESTRO:0006 HANCESTRO:0010 MONDO:0002050 HANCESTRO:0009 dose NCIT:C53554 Ann Arbor stage ER NCIT:C15329 NCIT:C18206 NCIT:C53555 MONDO:0011122 NCIT:C15262 organism part PD NCIT:C28079 PREFERRED body mass index NCIT:C18058 HIPAA weight NCIT:C65107"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001917 SHOULD MS:1001309 MS MRM fraction identifier PP MUST cleavage agent details RECOMMENDED ID PSI CF MS:1001313 MS:1001303 precursor mass tolerance fragment mass tolerance file uri TMT proteomexchange accession number HF RPPA FTP XL IMPORTANT REQUIRED NT SILAC TIP TA MS1 scan range MS2 analyzer type modification parameters MOD sample MM NOTE ELISA TS UNIMOD:737 RAW TOF ST label MS:1001251 UNIMOD:1 data file SDRF proteomics data acquisition method UNIMOD:35 MS:1001306 AC technical replicate fraction DDA CS KR scan window upper limit URL PRM scan window lower limit instrument LTQ UNIMOD MGF UNIMOD:4 URI exclamation SCIEX MSD UNIMOD:21 PRIDE MT DIA SRM PRIDE:0000663"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001917 SHOULD MS:1001309 MS MRM fraction identifier PP MUST cleavage agent details RECOMMENDED ID PSI CF MS:1001313 MS:1001303 precursor mass tolerance fragment mass tolerance TMT proteomexchange accession number HF RPPA FTP XL file uri REQUIRED NT SILAC TA MS1 scan range MS2 analyzer type modification parameters MOD MM ELISA TS UNIMOD:737 RAW TOF ST label MS:1001251 UNIMOD:1 data file SDRF proteomics data acquisition method UNIMOD:35 MS:1001306 AC technical replicate DDA CS KR scan window upper limit URL PRM scan window lower limit instrument LTQ UNIMOD MGF UNIMOD:4 URI SCIEX MSD UNIMOD:21 PRIDE MT DIA SRM PRIDE:0000663"
  }
];
